Yan B, Nam Y, Li L, Deek R, Li H, Ma S
Front Genet. 2025; 15:1494474.
PMID: 39840283
PMC: 11747409.
DOI: 10.3389/fgene.2024.1494474.
Jiang Y, Liao D, Zhu Q, Lu Y
Bioinformatics. 2025; 41(2).
PMID: 39799515
PMC: 11849959.
DOI: 10.1093/bioinformatics/btaf014.
Zhang Z, Liang Y, Mo S, Zhao M, Li Y, Zhang C
Physiol Rep. 2024; 13(1):e70174.
PMID: 39739369
PMC: 11685845.
DOI: 10.14814/phy2.70174.
Wang Z, Kaplan R, Burk R, Qi Q
Int J Mol Sci. 2024; 25(22).
PMID: 39596404
PMC: 11594421.
DOI: 10.3390/ijms252212337.
Oh V, Li R
Adv Sci (Weinh). 2024; 11(47):e2400458.
PMID: 39535493
PMC: 11653615.
DOI: 10.1002/advs.202400458.
The Role of the Gut Microbiome in Urinary Tract Infections: A Narrative Review.
Iqbal Z, Halkjaer S, Ghathian K, Heintz J, Petersen A
Nutrients. 2024; 16(21).
PMID: 39519448
PMC: 11547363.
DOI: 10.3390/nu16213615.
The Role of the Microbiome and of Radiotherapy-Derived Metabolites in Breast Cancer.
Herrera-Quintana L, Vazquez-Lorente H, Silva R, Olivares-Arancibia J, Reyes-Amigo T, Pires B
Cancers (Basel). 2024; 16(21).
PMID: 39518108
PMC: 11545256.
DOI: 10.3390/cancers16213671.
Decoding the diagnostic and therapeutic potential of microbiota using pan-body pan-disease microbiomics.
Schmartz G, Rehner J, Gund M, Keller V, Molano L, Rupf S
Nat Commun. 2024; 15(1):8261.
PMID: 39327438
PMC: 11427559.
DOI: 10.1038/s41467-024-52598-7.
Exploring microbial diversity and biosynthetic potential in zoo and wildlife animal microbiomes.
Schmartz G, Rehner J, Schuff M, Molano L, Becker S, Krawczyk M
Nat Commun. 2024; 15(1):8263.
PMID: 39327429
PMC: 11427580.
DOI: 10.1038/s41467-024-52669-9.
Systems Biology of Human Microbiome for the Prediction of Personal Glycaemic Response.
Kirtipal N, Seo Y, Son J, Lee S
Diabetes Metab J. 2024; 48(5):821-836.
PMID: 39313228
PMC: 11449821.
DOI: 10.4093/dmj.2024.0382.
A systematic framework for understanding the microbiome in human health and disease: from basic principles to clinical translation.
Ma Z, Zuo T, Frey N, Rangrez A
Signal Transduct Target Ther. 2024; 9(1):237.
PMID: 39307902
PMC: 11418828.
DOI: 10.1038/s41392-024-01946-6.
[Features of the relationship of intestinal microbiota indicators with clinical and biochemical parameters in obese young people].
Dushina T, Suplotova L, Klyashev S, Nikolenko M, Dorodneva E
Probl Endokrinol (Mosk). 2024; 70(4):84-93.
PMID: 39302868
PMC: 11551800.
DOI: 10.14341/probl13454.
Challenges for pathologists in implementing clinical microbiome diagnostic testing.
Gerasimova Y, Ali H, Nadeem U
J Pathol Clin Res. 2024; 10(5):e70002.
PMID: 39289163
PMC: 11407905.
DOI: 10.1002/2056-4538.70002.
Relationship between gut microbiota and multiple sclerosis: a scientometric visual analysis from 2010 to 2023.
Ouyang Q, Yu H, Xu L, Yu M, Zhang Y
Front Immunol. 2024; 15:1451742.
PMID: 39224586
PMC: 11366631.
DOI: 10.3389/fimmu.2024.1451742.
Microbial Ecology and Metabolism of Emerging Adulthood: Gut Microbiome Insights from a College Freshman Cohort.
Mohr A, Jasbi P, van Woerden I, Chi J, Gu H, Bruening M
Gut Microbes Rep. 2024; 1(1):1-23.
PMID: 39221110
PMC: 11361303.
DOI: 10.1080/29933935.2024.2387936.
Mosquito Gut Microbiota: A Review.
Liu H, Yin J, Huang X, Zang C, Zhang Y, Cao J
Pathogens. 2024; 13(8).
PMID: 39204291
PMC: 11357333.
DOI: 10.3390/pathogens13080691.
A computational model for potential microbe-disease association detection based on improved graph convolutional networks and multi-channel autoencoders.
Zhang C, Zhang Z, Zhang F, Zeng B, Liu X, Wang L
Front Microbiol. 2024; 15:1435408.
PMID: 39144226
PMC: 11322764.
DOI: 10.3389/fmicb.2024.1435408.
Investigation of the human-gut-kidney axis by fecal proteomics, highlights molecular mechanisms affected in CKD.
Lohia S, Valkenburg S, Stroggilos R, Lygirou V, Makridakis M, Zoidakis J
Heliyon. 2024; 10(12):e32828.
PMID: 38975221
PMC: 11226915.
DOI: 10.1016/j.heliyon.2024.e32828.
The association of maternal factors with the neonatal microbiota and health.
Zhu B, Edwards D, Spaine K, Edupuganti L, Matveyev A, Serrano M
Nat Commun. 2024; 15(1):5260.
PMID: 38898021
PMC: 11187136.
DOI: 10.1038/s41467-024-49160-w.
An energy landscape approach reveals the potential key bacteria contributing to the development of inflammatory bowel disease.
Zhang K, Nakaoka S
PLoS One. 2024; 19(6):e0302151.
PMID: 38885178
PMC: 11182530.
DOI: 10.1371/journal.pone.0302151.